All Substitutes


Loading...

Disclaimer

Want to know more?
Read Our Editorial Policy

Did you find this information helpful?

    
General Image 1
General Image 2
General Image 1
20% Off

Rockbon PTH Pen Injection

Prescription Required

cold-chain

Salt Composition : Teriparatide

Manufacturer : ABBOTT

Origin of Medicine : India

MRP: 6282
Price : 5026
You Save : 1256 (20%)

1 Pen Device(s)

Prepaid Only. Non-Returnable

Pincode
Delivery By -

Introduction to Rockbon Pth Pen Injection

Rockbon PTH Pen Injection contains the active component of Teriparatide. Rockbon PTH Pen Injection, a synthetic version of parathyroid hormone (PTH) produced by the parathyroid glands, is employed for treating osteoporosis. Osteoporosis is a condition marked by weakened bones, heightening the likelihood of fractures. Fractures caused by osteoporosis can severely affect an individual's quality of life, causing pain and restricting mobility. Rockbon PTH Pen functions by promoting the creation of new bone tissue and enhancing bone mineral density. This medication has been shown to accelerate bone healing in individuals with fractures. It promotes the formation of callus, the initial bridge of new bone that forms during the healing process, leading to faster and more efficient recovery.

Individuals who have a known hypersensitivity or allergic reaction to Rockbon PTH Pen Injection or any of its components should not use this medication. It is contraindicated in individuals with a history of skeletal malignancies, such as osteosarcoma, or those with bone metastases. If an individual has received prior radiation therapy involving the skeleton, the use of this medication is not advised due to the potential risk of osteosarcoma development. At mrmed.in, we offer competitive Rockbon PTH Pen prices, ensuring both quality and affordability for our customers.


Uses of Rockbon Pth Pen Injection

  • Postmenopausal osteoporosis
  • Glucocorticoid-induced osteoporosis

Therapeutic Effects of Rockbon Pth Pen Injection

Rockbon PTH Pen Injection exerts a therapeutic effect by stimulating the formation of new bone tissue and increasing bone mineral density. By activating osteoblasts, the cells responsible for bone formation, bone strength is enhanced, fracture risk is reduced, and bone healing is promoted. It offers significant benefits such as increased bone density, fracture risk reduction, and improved quality of life, and it serves as an alternative for individuals who have not responded well to other osteoporosis treatments.


Interaction of Rockbon Pth Pen Injection with other drugs

Inform the doctor about your medicines, including prescription, over-the-counter, nutritional or vitamin supplements, and herbal products. Certain medications may interact with Rockbon PTH Pen Injection, reducing its effectiveness by causing undesirable side effects.


More Information about Rockbon Pth Pen Injection

  • Store at controlled temperature, between 2-8°C.
  • Keep away from moisture, heat, and light.
  • It should not be frozen.
  • Keep away from children and pets.

How to consume Rockbon Pth Pen Injection

Rockbon PTH Pen Injection is typically administered by a healthcare professional. It is usually given as an injection. The healthcare provider will determine the dosage and duration of treatment based on the specific infection and individual factors.


Safety Advices for Rockbon Pth Pen Injection

Image Not Available  

Pregnancy

  

The safety of Rockbon PTH Pen Injection use during pregnancy has not been established. If you are pregnant or planning to become pregnant, discussing the potential risks and benefits with your healthcare professional is essential.

Image Not Available  

Breast Feeding

  

Women should consult a doctor while breastfeeding while taking Rockbon PTH Pen Injection.

Image Not Available  

Lungs

  

Suppose you have a pre-existing lung condition or are concerned about the safety of Rockbon PTH Pen Injection in your lungs. Consulting with your healthcare provider for personalised advice is recommended in that case.

Image Not Available  

Liver

  

If you have a liver condition or are concerned about the safety of Rockbon PTH Pen Injection, it is recommended to consult your healthcare provider for personalised advice.

Image Not Available  

Alcohol

  

It is generally advisable to avoid consuming alcohol while taking Rockbon PTH Pen Injection. Alcohol can impair the body's immune system, making it less effective in fighting infections.

Image Not Available  

Driving

  

People may experience side effects, including dizziness, drowsiness, or fatigue, after using Rockbon PTH Pen Injection. In that case, avoid driving or operating heavy machinery.


Side Effects of Rockbon Pth Pen Injection

Bonspark Pen cause some side effects like all medications, although not everyone will experience them. 

Serious:

  • Hypercalcemia
  • Allergic reactions that affect the skin and breathing
  • Skin reactions at the injection site include rashes, bruising, swelling, and itching
  • Osteosarcoma (a type of bone cancer)
  • Hypercalcemia (increased level of calcium)
  • Orthostatic hypotension (hypertension when standing after sitting or lying position)

Common:

  • Arthralgia
  • Nerve Pain
  • Nausea
  • Sickness
  • Headache
  • Dizziness
  • Increased sweating
  • Breathlessness
  • Muscle cramps
  • Increase in blood cholesterol levels
  • Chest pain
  • Burning sensation below the breast bone
  • Anaemia

Word of Advice

Prior to initiating Rockbon PTH Pen Injection, it is crucial to disclose any preexisting medical conditions, particularly those related to bones or metabolism, as well as provide information about any medications or supplements being taken to your healthcare professional. Extra care should be taken for individuals with a history of skeletal malignancies or bone metastases, as Rockbon PTH Pen Injection is not recommended in such cases. 

Regular monitoring of serum calcium levels is essential to identify and manage hypercalcemia. The Rockbon PTH Pen Injection should be used cautiously in patients with orthostatic hypotension or pre-existing hyperparathyroidism. The duration of treatment with this medication is generally limited, and its use is not advised in pediatric patients. If you are pregnant or breastfeeding, discussing the potential risks and benefits of the Rockbon PTH Pen Injection with your healthcare provider before considering its use is crucial.


FAQs

Q 1. Can Rockbon PTH Pen Injection be used in men with osteoporosis?

Yes, Rockbon PTH Pen Injection can be used in men with osteoporosis. While osteoporosis is more commonly associated with women, men can also develop the condition. It can effectively increase bone density and reduce fracture risk in men with osteoporosis.

Q 2. Can Rockbon PTH Pen Injection be used in individuals with a history of kidney disease?

Rockbon PTH Pen Injection does not undergo significant renal excretion so it can be used in individuals with mild to moderate kidney impairment. However, caution is advised in individuals with severe kidney disease, as there is limited data on the safety and effectiveness of this medication in this population.

Q 3. Can Rockbon PTH Pen Injection be used in individuals with a history of fractures?

Rockbon PTH Pen Injection is commonly prescribed for individuals with a history of fragility fractures. Fragility fractures occur due to minimal trauma or impact and are often associated with osteoporosis. It helps to increase bone density and reduce the risk of future fractures in individuals with osteoporosis, including those who have previously experienced fractures.

Q 4. Can Rockbon PTH Pen Injection be used as a first-line treatment for osteoporosis?

Rockbon PTH Pen Injection is typically not used as a first-line treatment for osteoporosis. It is usually considered when other osteoporosis medications are ineffective, or individuals have a high fracture risk. However, whether it is appropriate as a first-line treatment depends on individual factors and should be discussed with your healthcare provider.

Q 5. What are the potential long-term effects of Rockbon PTH Pen Injection?

The long-term effects of Rockbon PTH Pen Injection have yet to be well understood, particularly beyond the recommended treatment duration of 2 years. The risk of osteosarcoma, a potential rare side effect, is one of the main concerns associated with long-term use.

Q 6. What are the side effects of Rockbon PTH Pen Injection?

Rockbon PTH Pen Injection may cause side effects, including common ones such as injection site reactions, nausea, dizziness, and headache. Serious side effects, though rare, can include the development of osteosarcoma, a type of bone cancer, and the potential for hypercalcemia, which can lead to symptoms like excessive thirst and muscle weakness.


Fact Box of Rockbon Pth Pen Injection

Molecule name: TeriparatideTherapeutic class: Bone formulation stimulator
Pharmacological class: Parathyroid hormone analogue

Indications:

1. Postmenopausal osteoporosis

2. Glucocorticoid-induced osteoporosis


References

  1. Eli Lilly and Company Limited, Electronic medicines compendium (EMC), [Revised on 06 Feb 2023], [Accessed on 1st June 2023], https://www.medicines.org.uk/emc/files/pil.3634.pdf
  2. Eli Lilly and Company, US Food and Drug Administration, [Revised on September 2021],[Accessed on 1st June 2023], https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021318Orig1s056lbl.pdf
  3. KD Tripathi, Hormones and Drugs Affecting Calcium Balance, Essentials of Medical Pharmacology, 8th Edition, 2019, 360-372

Disclaimer

MrMed’s primary intention is to ensure that its consumers get information that experts, accurate and trustworthy, review. The information and contents of this website are for informational purposes only. They are not intended to substitute for professional medical advice, diagnosis, or treatment. Please seek your doctor's advice and discuss all your queries related to any disease or medicine. Do not disregard professional medical advice or delay seeking it because of something you have read on MrMed. Our mission is to support, not replace, the doctor-patient relationship.